The DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index.
EASL Recommendations on Treatment of Hepatitis C 2015
Open accessAbstract
Hepatitis C virus (HCV) infection is one of the main causes of chronic liver disease worldwide [1]. The long-term impact of HCV infection is highly variable, ranging from minimal histological changes to extensive fibrosis and cirrhosis with or without hepatocellular carcinoma (HCC). The number of chronically infected persons worldwide is estimated to be about 160million, but most are unaware of their infection. The implementation of extended criteria for screening for HCV is a subject of major debate among different stakeholders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection
Fried, M. W., Shiffman, M. L., Reddy, K. R., Smith, C., Marinos, G., Gonçales, F. L., Häussinger, D., Diago, M., Carosi, G., Dhumeaux, D., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020047 · Cited by 6,389
Manns, M. P., McHutchison, J. G., Gordon, S. C., Rustgi, V. K., Shiffman, M., Reindollar, R., Goodman, Z. D., Koury, K., Ling, M.-H., & Albrecht, J. K. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06102-5 · Cited by 6,029
Hadziyannis, S. J., Sette, H., Morgan, T. R., Balan, V., Diago, M., Marcellin, P., Ramadori, G., Bodenheimer, H., Bernstein, D., Rizzetto, M., et al. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-5-200403020-00010 · Cited by 2,836
Global epidemiology of hepatitis C virus infection
Shepard, C. W., Finelli, L., & Alter, M. J. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70216-4 · Cited by 2,758
Boceprevir for Untreated Chronic HCV Genotype 1 Infection
Poordad, F., McCone, J., Bacon, B. R., Bruno, S., Manns, M. P., Sulkowski, M. S., Jacobson, I. M., Reddy, K. R., Goodman, Z. D., Boparai, N., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1010494 · Cited by 2,520
Castéra, L., Vergniol, J., Foucher, J., Le Bail, B., Chanteloup, E., Haaser, M., Darriet, M., Couzigou, P., & de Lédinghen, V. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.11.018 · Cited by 2,487
Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection
Jacobson, I. M., McHutchison, J. G., Dusheiko, G., Di Bisceglie, A. M., Reddy, K. R., Bzowej, N. H., Marcellin, P., Muir, A. J., Ferenci, P., Flisiak, R., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1012912 · Cited by 2,398
Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection
Lawitz, E., Mangia, A., Wyles, D., Rodriguez-Torres, M., Hassanein, T., Gordon, S. C., Schultz, M., Davis, M. N., Kayali, Z., Reddy, K. R., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1214853 · Cited by 1,788
Diagnosis, management, and treatment of hepatitis C†
Strader, D. B., Wright, T., Thomas, D. L., & Seeff, L. B. (2004) · Hepatology · doi:10.1002/hep.20119 · Cited by 1,709
Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection
Afdhal, N., Zeuzem, S., Kwo, P., Chojkier, M., Gitlin, N., Puoti, M., Romero-Gomez, M., Zarski, J.-P., Agarwal, K., Buggisch, P., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402454 · Cited by 1,705
Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection
Bacon, B. R., Gordon, S. C., Lawitz, E., Marcellin, P., Vierling, J. M., Zeuzem, S., Poordad, F., Goodman, Z. D., Sings, H. L., Boparai, N., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009482 · Cited by 1,626
Telaprevir for Retreatment of HCV Infection
Zeuzem, S., Andreone, P., Pol, S., Lawitz, E., Diago, M., Roberts, S., Focaccia, R., Younossi, Z., Foster, G. R., Horban, A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1013086 · Cited by 1,546
van der Meer, A. J., Veldt, B. J., Feld, J. J., Wedemeyer, H., Dufour, J.-F., Lammert, F., Duarte-Rojo, A., Heathcote, E. J., Manns, M. P., Kuske, L., et al. (2012) · JAMA · doi:10.1001/jama.2012.144878 · Cited by 1,510
Andrews, J., Guyatt, G., Oxman, A. D., Alderson, P., Dahm, P., Falck-Ytter, Y., Nasser, M., Meerpohl, J., Post, P. N., Kunz, R., et al. (2013) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2012.03.013 · Cited by 1,416
Evolving epidemiology of hepatitis C virus
Lavanchy, D. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03432.x · Cited by 1,318
Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection
Afdhal, N., Reddy, K. R., Nelson, D. R., Lawitz, E., Gordon, S. C., Schiff, E., Nahass, R., Ghalib, R., Gitlin, N., Herring, R., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1316366 · Cited by 1,307
Nelson, P. K., Mathers, B. M., Cowie, B., Hagan, H., Des Jarlais, D., Horyniak, D., & Degenhardt, L. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61097-0 · Cited by 1,267
Daclatasvir plus Sofosbuvir for Previously Treated or Untreated Chronic HCV Infection
Sulkowski, M. S., Gardiner, D. F., Rodriguez-Torres, M., Reddy, K. R., Hassanein, T., Jacobson, I., Lawitz, E., Lok, A. S., Hinestrosa, F., Thuluvath, P. J., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1306218 · Cited by 1,190
Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without Cirrhosis
Kowdley, K. V., Gordon, S. C., Reddy, K. R., Rossaro, L., Bernstein, D. E., Lawitz, E., Shiffman, M. L., Schiff, E., Ghalib, R., Ryan, M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402355 · Cited by 1,130
Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options
Jacobson, I. M., Gordon, S. C., Kowdley, K. V., Yoshida, E. M., Rodriguez-Torres, M., Sulkowski, M. S., Shiffman, M. L., Lawitz, E., Everson, G., Bennett, M., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1214854 · Cited by 1,090
EASL Clinical Practice Guidelines: Management of hepatitis C virus infection
(2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.02.023 · Cited by 1,088
Orens, J. B., Estenne, M., Arcasoy, S., Conte, J. V., Corris, P., Egan, J. J., Egan, T., Keshavjee, S., Knoop, C., Kotloff, R., et al. (2006) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2006.03.011 · Cited by 1,073
The association between hepatitis C infection and survival after orthotopic liver transplantation
Forman, L. M., Lewis, J. D., Berlin, J. A., Feldman, H. I., & Lucey, M. R. (2002) · Gastroenterology · doi:10.1053/gast.2002.32418 · Cited by 1,031
Treatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin
Feld, J. J., Kowdley, K. V., Coakley, E., Sigal, S., Nelson, D. R., Crawford, D., Weiland, O., Aguilar, H., Xiong, J., Pilot-Matias, T., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1315722 · Cited by 903
ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin for Hepatitis C with Cirrhosis
Poordad, F., Hezode, C., Trinh, R., Kowdley, K. V., Zeuzem, S., Agarwal, K., Shiffman, M. L., Wedemeyer, H., Berg, T., Yoshida, E. M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402869 · Cited by 874
Micallef, J. M., Kaldor, J. M., & Dore, G. J. (2006) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2005.00651.x · Cited by 871
EASL Clinical Practice Guidelines: Management of hepatitis C virus infection
(2014) · Journal of Hepatology · doi:10.1016/j.jhep.2013.11.003 · Cited by 855
Morgan, R. L., Baack, B., Smith, B. D., Yartel, A., Pitasi, M., & Falck-Ytter, Y. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-5-201303050-00005 · Cited by 829
Lawitz, E., Sulkowski, M. S., Ghalib, R., Rodriguez-Torres, M., Younossi, Z. M., Corregidor, A., DeJesus, E., Pearlman, B., Rabinovitz, M., Gitlin, N., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)61036-9 · Cited by 818
Sofosbuvir and Ribavirin in HCV Genotypes 2 and 3
Zeuzem, S., Dusheiko, G. M., Salupere, R., Mangia, A., Flisiak, R., Hyland, R. H., Illeperuma, A., Svarovskaia, E., Brainard, D. M., Symonds, W. T., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1316145 · Cited by 795
ABT-450/r–Ombitasvir and Dasabuvir with or without Ribavirin for HCV
Ferenci, P., Bernstein, D., Lalezari, J., Cohen, D., Luo, Y., Cooper, C., Tam, E., Marinho, R. T., Tsai, N., Nyberg, A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402338 · Cited by 693
Nelson, D. R., Cooper, J. N., Lalezari, J. P., Lawitz, E., Pockros, P. J., Gitlin, N., Freilich, B. F., Younes, Z. H., Harlan, W., Ghalib, R., et al. (2015) · Hepatology · doi:10.1002/hep.27726 · Cited by 689
Side effects of therapy of hepatitis C and their management
Fried, M. W. (2002) · Hepatology · doi:10.1002/hep.1840360730 · Cited by 556
Prieto, M., Berenguer, M., Rayón, J. M., Córdoba, J., Argüello, L., Carrasco, D., García-Herola, A., Olaso, V., De Juan, M., Gobernado, M., et al. (1999) · Hepatology · doi:10.1002/hep.510290122 · Cited by 537
Gerlach, J. T., Diepolder, H. M., Zachoval, R., Gruener, N. H., Jung, M.-C., Ulsenheimer, A., Schraut, W. W., Schirren, C. A., Waechtler, M., Backmund, M., et al. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00668-1 · Cited by 524
New Hepatitis C Therapies: The Toolbox, Strategies, and Challenges
Pawlotsky, J. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.03.003 · Cited by 518
Retreatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin
Zeuzem, S., Jacobson, I. M., Baykal, T., Marinho, R. T., Poordad, F., Bourlière, M., Sulkowski, M. S., Wedemeyer, H., Tam, E., Desmond, P., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1401561 · Cited by 517
Hepatitis C virus kinetics during and immediately after liver transplantation
Garcia-Retortillo, M., Forns, X., Feliu, A., Moitinho, E., Costa, J., Navasa, M., Rimola, A., & Rodes, J. (2002) · Hepatology · doi:10.1053/jhep.2002.31773 · Cited by 503
Jacobson, I. M., Dore, G. J., Foster, G. R., Fried, M. W., Radu, M., Rafalsky, V. V., Moroz, L., Craxi, A., Peeters, M., Lenz, O., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60494-3 · Cited by 437
Manns, M., Marcellin, P., Poordad, F., de Araujo, E. S. A., Buti, M., Horsmans, Y., Janczewska, E., Villamil, F., Scott, J., Peeters, M., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60538-9 · Cited by 376
Andreone, P., Colombo, M. G., Enejosa, J. V., Koksal, I., Ferenci, P., Maieron, A., Müllhaupt, B., Horsmans, Y., Weiland, O., Reesink, H. W., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.04.045 · Cited by 365
Charlton, M., Gane, E. J., Manns, M. P., Brown, R. S., Curry, M. P., Kwo, P. Y., Fontana, R. J., Gilroy, R. K., Teperman, L. W., Muir, A. J., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.10.001 · Cited by 347
Fibrosis progression after liver transplantation in patients with recurrent hepatitis C
Neumann, U. P., Berg, T., Bahra, M., Seehofer, D., Langrehr, J. M., Neuhaus, R., Radke, C., & Neuhaus, P. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.06.029 · Cited by 339
Curry, M. P., Forns, X., Chung, R. T., Terrault, N. A., Brown, R., Fenkel, J. M., Gordon, F., O’Leary, J., Kuo, A., Schiano, T., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2014.09.023 · Cited by 334
Swain, M. G., Lai, M., Shiffman, M. L., Cooksley, W. G. E., Zeuzem, S., Dieterich, D. T., Abergel, A., Pessôa, M. G., Lin, A., Tietz, A., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.07.009 · Cited by 328
Blasco, A., Forns, X., Carrión, J. A., García-Pagán, J. C., Gilabert, R., Rimola, A., Miquel, R., Bruguera, M., García-Valdecasas, J.-C., Bosch, J., et al. (2006) · Hepatology · doi:10.1002/hep.21090 · Cited by 293
Berenguer, M., Palau, A., Aguilera, V., Rayón, J.-M., Juan, F. S., & Prieto, M. (2008) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2007.02126.x · Cited by 283
Martin, N. K., Vickerman, P., Foster, G. R., Hutchinson, S. J., Goldberg, D. J., & Hickman, M. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.08.029 · Cited by 230
Forns, X., Charlton, M., Denning, J., McHutchison, J. G., Symonds, W. T., Brainard, D., Brandt‐Sarif, T., Chang, P., Kivett, V., Castells, L., et al. (2015) · Hepatology · doi:10.1002/hep.27681 · Cited by 229
Hagan, H., Pouget, E. R., Des Jarlais, D. C., & Lelutiu-Weinberger, C. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwn237 · Cited by 222
Cost–Effectiveness of Hepatitis C Virus Antiviral Treatment for Injection Drug User Populations
Martin, N. K., Vickerman, P., Miners, A., Foster, G. R., Hutchinson, S. J., Goldberg, D. J., & Hickman, M. (2012) · Hepatology · doi:10.1002/hep.24656 · Cited by 221
Castéra, L., Sebastiani, G., Le Bail, B., de Lédinghen, V., Couzigou, P., & Alberti, A. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2009.11.008 · Cited by 214
Hofer, H., Watkins-Riedel, T., Janata, O., Penner, E., Holzmann, H., Steindl-Munda, P., Gangl, A., & Ferenci, P. (2003) · Hepatology · doi:10.1053/jhep.2003.50019 · Cited by 203
Arase, Y., Kobayashi, M., Suzuki, F., Suzuki, Y., Kawamura, Y., Akuta, N., Kobayashi, M., Sezaki, H., Saito, S., Hosaka, T., et al. (2013) · Hepatology · doi:10.1002/hep.26087 · Cited by 191
The neglected hepatitis C virus genotypes 4, 5 and 6: an international consensus report
Antaki, N., Craxi, A., Kamal, S., Moucari, R., Van der Merwe, S., Haffar, S., Gadano, A., Zein, N., Lai, C. L., Pawlotsky, J.-M., et al. (2010) · Liver International · doi:10.1111/j.1478-3231.2009.02188.x · Cited by 186
Acute Hepatitis C: A Systematic Review.: CME
Kamal, S. M. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.01825.x · Cited by 180
Martinot‐Peignoux, M., Stern, C., Maylin, S., Ripault, M., Boyer, N., Leclere, L., Castelnau, C., Giuily, N., El Ray, A., Cardoso, A., et al. (2010) · Hepatology · doi:10.1002/hep.23444 · Cited by 176
Management of chronic viral hepatitis before and after renal transplantation
Gane, E., & Pilmore, H. (2002) · Transplantation · doi:10.1097/00007890-200208270-00001 · Cited by 175
Laboratory Diagnostics for Hepatitis C Virus Infection
Kamili, S., Drobeniuc, J., Araujo, A. C., & Hayden, T. M. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis368 · Cited by 173
Alcohol Use and Treatment of Hepatitis C Virus: Results of a National Multicenter Study
Anand, B. S., Currie, S., Dieperink, E., Bini, E. J., Shen, H., Ho, S. B., & Wright, T. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.02.023 · Cited by 162
The European AIDS Treatment Network (NEAT) Acute Hepatitis C Infection Consensus Panel (2010) · AIDS · doi:10.1097/qad.0b013e328343443b · Cited by 162
What Is Killing People with Hepatitis C Virus Infection?
Grebely, J., & Dore, G. J. (2011) · Seminars in Liver Disease · doi:10.1055/s-0031-1297922 · Cited by 161
Doab, A., Treloar, C., & Dore, G. J. (2005) · Clinical Infectious Diseases · doi:10.1086/427446 · Cited by 144
Lenz, O., Verbinnen, T., Fevery, B., Tambuyzer, L., Vijgen, L., Peeters, M., Buelens, A., Ceulemans, H., Beumont, M. G., Picchio, G., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.11.032 · Cited by 132
Singal, A. K., Freeman, D. H., Jr., & Anand, B. S. (2010) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2010.04414.x · Cited by 122
Vermehren, J., Kau, A., Gärtner, B. C., Göbel, R., Zeuzem, S., & Sarrazin, C. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.00755-08 · Cited by 116
Diagnosis and management of chronic viral hepatitis: Antigens, antibodies and viral genomes
Chevaliez, S., & Pawlotsky, J. (2008) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2008.11.004 · Cited by 105
Deterding, K., Grüner, N. H., Buggisch, P., Wiegand, J., Galle, P. R., Spengler, U., Hinrichsen, H. M., Berg, T., Potthoff, A., Malek, N. P., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70059-8 · Cited by 104
Reinfection with hepatitis C virus following sustained virological response in injection drug users
Grebely, J., Knight, E., Ngai, T., Genoway, K. A., Raffa, J. D., Storms, M. M., Gallagher, L., Krajden, M., Dore, G. J., Duncan, F., et al. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2010.06238.x · Cited by 94
Interferon as treatment for acute hepatitis C
Cammà, C., Almasio, P. L., & Craxı̀, A. (1996) · Digestive Diseases and Sciences · doi:10.1007/bf02088245 · Cited by 79
Darke, S. G., Kaye, S. S., & Duflou, J. A. (2006) · Addiction · doi:10.1111/j.1360-0443.2006.01601.x · Cited by 77
Acute hepatitis C: diagnosis and management
Mondelli, M. U., Cerino, A., & Cividini, A. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.10.017 · Cited by 76
Siu, L., Foont, J., & Wands, J. (2009) · Seminars in Liver Disease · doi:10.1055/s-0029-1214374 · Cited by 74
Telaprevir in the Treatment of Acute Hepatitis C Virus Infection in HIV-Infected Men
Fierer, D. S., Dieterich, D. T., Mullen, M. P., Branch, A. D., Uriel, A. J., Carriero, D., van Seggelen, W. O., Hijdra, R. M., Cassagnol, D. G., for the New York Acute Hepatitis C Surveillance Network, et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit799 · Cited by 74
Treatment options in patients with decompensated cirrhosis, pre- and post-transplantation
Gambato, M., Lens, S., Navasa, M., & Forns, X. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.07.020 · Cited by 71
Currie, S. L., Ryan, J. C., Tracy, D., Wright, T. L., George, S., McQuaid, R., Kim, M., Shen, H., & Monto, A. (2007) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2007.09.011 · Cited by 63
Grebely, J., Raffa, J., Lai, C., Kerr, T., Fischer, B., Krajden, M., Dore, G., & Tyndall, M. (2011) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2010.01279.x · Cited by 60
Bruggmann, P., Dampz, M., Gerlach, T., Kravecz, L., & Falcato, L. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.02.016 · Cited by 50
Interferon for acute hepatitis C
Myers, R. P., Regimbeau, C., Thévenot, T., Leroy, V., Mathurin, P., Opolon, P., Zarski, J., & Poynard, T. (2001) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000369 · Cited by 45
Moon, C., Jung, K. S., Kim, D. Y., Baatarkhuu, O., Park, J. Y., Kim, B. K., Kim, S. U., Ahn, S. H., & Han, K. (2014) · Digestive Diseases and Sciences · doi:10.1007/s10620-014-3361-6 · Cited by 42
Lan, C. L., Guillygomarc’h, A., Danielou, H., Dréau, G. L., Lainé, F., Vedeilhie, C., Deugnier, Y., Brissot, P., Guyader, D., & Moirand, R. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.05.021 · Cited by 35
Rodis, J. L., & Kibbe, P. J. (2010) · Gastroenterology Nursing · doi:10.1097/sga.0b013e3181f443cb · Cited by 31
Cited by
EASL Recommendations on Treatment of Hepatitis C 2018
Pawlotsky, J.-M., Negro, F., Aghemo, A., Berenguer, M., Dalgard, O., Dusheiko, G., Marra, F., Puoti, M., & Wedemeyer, H. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.026 · Cited by 2,827
EASL recommendations on treatment of hepatitis C: Final update of the series☆
Pawlotsky, J.-M., Negro, F., Aghemo, A., Berenguer, M., Dalgard, O., Dusheiko, G., Marra, F., Puoti, M., & Wedemeyer, H. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.08.018 · Cited by 1,252
Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection
Feld, J. J., Jacobson, I. M., Hézode, C., Asselah, T., Ruane, P. J., Gruener, N., Abergel, A., Mangia, A., Lai, C.-L., Chan, H. L. Y., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1512610 · Cited by 1,106
Reig, M., Mariño, Z., Perelló, C., Iñarrairaegui, M., Ribeiro, A., Lens, S., Díaz, A., Vilana, R., Darnell, A., Varela, M., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.04.008 · Cited by 1,018
EASL Recommendations on Treatment of Hepatitis C 2016
(2017) · Journal of Hepatology · doi:10.1016/j.jhep.2016.09.001 · Cited by 985
Metadata
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2015-07
- Volume
- 63
- Issue
- 1
- Pages
- 199-236
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W4211051574
- Cited by
- 1,156
- References
- 82
- FWCI
- 148.39
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.